December 6, 2013

McKesson's Health Mart pharmacy franchisees recently gained access to a tool that has the potential of giving community pharmacy a leg up on the competition in the coming years. EQuIPP, from Pharmacy Quality Solutions, does just that — equips independents with individual store data that marks the performance of their pharmacy vs. a national benchmark.

It's putting the pestle where the mortar is — retail pharmacy has the patient touchpoints and data-tracking wherewithal to make a material impact on patient outcomes. Important, because that's what the new year will bring — more and more healthcare payers looking to improve their own patient outcomes. And what better way to do it than to partner with outperforming pharmacies?

December 6, 2013

A study conducted among rural patients at Thrifty White Pharmacy locations in the Midwest and published in the November/December issue of the Journal of the American Pharmacists Association found that patients who received appointment-based medication synchronization were up to six times more likely to adhere to their therapies than those who didn't receive them.

Over the years, study after study has shown that pharmacists can play a crucial role in ensuring that patients take their drugs when they're supposed to and as instructed. And poor medication adherence is no small issue, as studies have shown it costs the country nearly $300 billion per year, in addition to contributing to poor health outcomes. It's been said that improvements in medication adherence can be the equivalent of a blockbuster drug, and according to the National Coalition on Health Care, self-management of chronic diseases could save $10 for every $1 spent.

December 6, 2013

Teva Pharmaceutical Industries' U.S. subsidiary has launched a generic drug for treating warts and skin lesions, the company said.

December 5, 2013

Compounding pharmacies that produce sterile drugs can register as outsourcing facilities and may be exempt from certain Food and Drug Administration approval requirements, according to a document published on the FDA's website.

December 4, 2013

Cardinal Health Foundation recently awarded more than $350,000 in grant funding to 29 nonprofit organizations that are dedicated to the fight against prescription drug abuse, the organization announced Wednesday.

December 4, 2013

Mail-order pharmacies frequently charge Medicare prescription drug plans more than community pharmacies do for filling prescriptions, a new analysis by the U.S. Centers for Medicare and Medicaid Services has concluded.

December 4, 2013

The Food and Drug Administration has approved a new topical drug for treating scars made by Oculus Innovative Sciences, the drug maker said Wednesday.

December 4, 2013

Walgreens on Wednesday reported November sales of $6.1 billion, an increase of 4.1% for the same month in fiscal 2013.

December 3, 2013

Cardinal Health recently enhanced its Reimbursement Consulting Services offering, which helps retail pharmacies ensure the accuracy of third-party reimbursement by identifying reimbursement errors and recommending strategies for correcting them.

December 3, 2013

The Food and Drug Administration has given tentative approval to a generic drug for treating community-acquired pneumonia, agency records showed.

December 3, 2013

Forest Labs is spending at least $240 million to buy rights to a psychiatric drug made by Merck, the New York-based drug maker said.

December 3, 2013

Takeda Pharmaceutical Co., the largest drug maker in Japan, has hired the head of GlaxoSmithKline's vaccines division as its COO, Takeda said.

December 3, 2013

Impax Labs has settled a patent-infringement suit filed by Purdue Pharma concerning the opioid painkiller OxyContin, Impax said Tuesday.

December 3, 2013

McKesson will be introducing hospital and health systems pharmacy leaders to new ideas and emerging solutions for their top issues at the American Society of Health-System Pharmacists Midyear Clinical Meeting 2013, which runs from Dec. 8 to 12.

December 3, 2013

Officials in Rhode Island may set up a registry that would allow doctors and pharmacists to track patients who have problems with drug abuse, according to published reports.

December 3, 2013

The Food and Drug Administration has given tentative approval to a generic drug used to treat prostate disease, agency records showed.

December 2, 2013

The Food and Drug Administration has designated a drug made by Teva Pharmaceutical Industries as an orphan drug, the company said.

December 2, 2013

Sandoz will market an authorized generic version of an attention deficit hyperactivity disorder drug made by Shire under a contract between the two companies, Shire said Monday.

November 26, 2013

German chemical and pharmaceutical giant Bayer plans to buy Norwegian drug maker Algeta for $2.4 billion, Algeta confirmed Tuesday.

November 26, 2013

The Food and Drug Administration has accepted Purdue Pharma's regulatory approval application for a new opioid drug, Purdue said Tuesday.

November 26, 2013

Generic drug maker Hospira will have its investor conference next week, the company said Tuesday.

November 25, 2013

The Food and Drug Administration has approved a new treatment made by Johnson & Johnson for hepatitis C, the drug maker said.

November 25, 2013

Federal regulators are lifting some restrictions on a diabetes drug that were placed two years ago after studies linked the drug to increased cardiovascular risk.

November 22, 2013

Sandoz has launched an authorized generic version of a topical drug for treating actinic keratosis, the company said.